Working… Menu
Trial record 28 of 44 for:    Malignant Hyperthermia 5

Tinostamustine and Nivolumab in Advanced Melanoma (ENIgMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03903458
Recruitment Status : Recruiting
First Posted : April 4, 2019
Last Update Posted : April 8, 2019
Information provided by (Responsible Party):
Markus Joerger, Cantonal Hospital of St. Gallen

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 15, 2021
Estimated Study Completion Date : March 15, 2024